Exelon (EXC) Receives a Hold From Scotiabank
Exelon Is Maintained at Overweight by Barclays
Exelon Analyst Ratings
Barclays Maintains Exelon(EXC.US) With Buy Rating, Raises Target Price to $44
Guggenheim Adjusts Exelon Price Target to $38 From $39
Exelon Analyst Ratings
Morgan Stanley Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $45
Exelon (EXC) Receives a Hold From Morgan Stanley
UBS Maintains Neutral on Exelon, Raises Price Target to $43
Exelon Analyst Ratings
Jefferies Initiates Coverage On Exelon With Buy Rating, Announces Price Target of $46
Jefferies Upgrades Exelon(EXC.US) to Buy Rating, Raises Target Price to $46
Argus Research Initiates Exelon(EXC.US) With Buy Rating
Argus Research Keeps Their Buy Rating on Exelon (EXC)
Exelon Analyst Ratings
Morgan Stanley Maintains Exelon(EXC.US) With Hold Rating, Raises Target Price to $42
Exelon (EXC) Receives a Hold From Morgan Stanley
Morgan Stanley Adjusts Price Target on Exelon to $42 From $39, Maintains Equalweight Rating
Exelon Analyst Ratings
RBC Capital Adjusts Price Target on Exelon to $40 From $41, Maintains Sector Perform Rating